Bunkerhill MAC vs Cleerly ISCHEMIA

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Bunkerhill MAC

by Bunkerhill Health

Cleerly ISCHEMIA

by Cleerly

AI Verdict

These tools are adjacent rather than direct competitors, as they address distinct cardiovascular conditions using different types of CT scans. Bunkerhill MAC focuses on detecting and quantifying mitral annular calcification on routine CTs for early risk identification. Cleerly ISCHEMIA, conversely, analyzes CCTA scans to assess coronary artery ischemia, plaque, and stenosis for diagnosis and treatment planning of coronary artery disease.

Choose Bunkerhill MAC if…

Choose Bunkerhill MAC if your primary goal is to opportunistically identify patients at increased cardiovascular risk by detecting and quantifying Mitral Annular Calcification (MAC) on routine, non-gated chest CT scans. This tool is ideal for integrating early risk identification into broader population health strategies and leveraging automated workflows for care coordination within the Carebricks platform.

View Bunkerhill MAC →

Choose Cleerly ISCHEMIA if…

Choose Cleerly ISCHEMIA if you need a detailed, non-invasive assessment of coronary artery ischemia and plaque characteristics from CCTA scans to guide personalized diagnosis and treatment planning for suspected coronary artery disease. This tool provides vessel-level ischemia likelihood, FFR estimation, and comprehensive reports to inform clinical decisions.

View Cleerly ISCHEMIA →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Bunkerhill MAC	Cleerly ISCHEMIA
Pricing	Contact for pricing	Contact for details
Deployment	Cloud-based, integrated with existing EHRs and clinical systems via Carebricks platform.	Web-based platform; data transfer via Cleerly Proxy (VPN or virtual appliance)
FDA Status	Yes AI-estimated	1 AI-estimated

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Bunkerhill MAC	Cleerly ISCHEMIA
Name	Bunkerhill MAC	Cleerly ISCHEMIA
Company	Bunkerhill Health	Cleerly
Tagline	Generative AI for clinical reasoning and action.	AI-Powered Precision for Non-Invasive Ischemia Detection
Primary Detection Target	Detects and quantifies mitral annular calcification (MAC)	Determines the likelihood of coronary artery ischemia at a vessel level
Scan Type Analyzed	Routine, non-gated chest CT scans	CCTA scans
Integration	Integrated with existing EHRs and clinical systems via Carebricks platform.	Integration with PowerScribe via API

Videos

Demos, reviews, and walkthroughs featuring Bunkerhill MAC and Cleerly ISCHEMIA.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What is the primary clinical application of each tool?

Bunkerhill MAC is an FDA-cleared AI algorithm that detects and quantifies mitral annular calcification (MAC) on routine CT scans, aiding early cardiovascular risk identification and care coordination. Cleerly ISCHEMIA is an FDA-cleared AI tool that analyzes CCTA scans to non-invasively determine the likelihood of coronary artery ischemia at a vessel level, assisting physicians in personalized diagnosis and treatment planning for heart disease.

What type of imaging scan is required for each AI tool?

Bunkerhill MAC analyzes routine, non-gated chest CT scans. Cleerly ISCHEMIA requires Coronary CT Angiography (CCTA) scans for its analysis.

How do the outputs of these tools differ in supporting clinical decision-making?

Bunkerhill MAC provides AI-powered detection and quantification of MAC, identifying patients at increased cardiovascular risk and supporting automated workflows for follow-up and care coordination. Cleerly ISCHEMIA offers vessel-level ischemia likelihood determination, non-invasive fractional flow reserve (FFR) estimation, coronary plaque characterization (volume, type, location), and stenosis severity assessment to guide personalized treatment.

What specific cardiovascular conditions do these tools primarily address?

Bunkerhill MAC specifically targets the detection and quantification of Mitral Annular Calcification (MAC) to identify increased cardiovascular risk. Cleerly ISCHEMIA focuses on determining the likelihood of coronary artery ischemia and characterizing coronary plaque to aid in heart disease diagnosis and treatment.

More Comparisons

Assert-IQ vs Rapid Enterprise Platform

AISAP Cardio vs Rapid Enterprise Platform

AngioWaveNet vs Rapid Enterprise Platform

CorVista System with PH Add-On vs Rapid Enterprise Platform

More matchups featuring Bunkerhill MAC or Cleerly ISCHEMIA

Backers

Who funded each tool's parent company.